Insights

Manufacturers

Drug advertisement in Canada: What you need to know

Manufacturers

Regulatory compliance: Navigating the Canadian landscape for specialty products

Infographic: Patient support program enrollment process comparison

Manufacturers

Unraveling payer trends: Critical insights on healthcare decision-making strategies

Shaila Yoshida

Manufacturers

Streamlining AE Management with Automated Solutions

Physician Practices

Biosimilars pipeline report: A guide for understanding the growing market

Manufacturers

Biosimilars pipeline report: A guide for understanding the growing market

Manufacturers

Panel discussion: Strategically prepare for IRA Part D redesign

Manufacturers

HTA Quarterly Fall 2024

Rianne Ernst, MSc; Carlijn de Sonnaville, MSc; Silvia Rohr, PhD; Mark Tolboom, MSc

In this special themed edition, our colleagues at Vintura, a Cencora company, explore the potential of value-based partnerships (VBPs). First outlining the principles, goals and potential benefits of VBPs, this edition also provides two case studies that demonstrate how successful partnerships work in practice.

Embracing value-based partnerships: A path to enhanced healthcare outcomes

Vintura, a Cencora company

Manufacturers

Unwinding the patient journey: Simplifying experiences and overcoming patient access barriers

Dale Hanna

Manufacturers

From Potential to Value: Carving a Slice of the CGT ‘PIE'

Manufacturers

Building patient trust and empowerment to improve the treatment experience

Manufacturers

ThinkLive Cell and Gene Therapy Summit 2024

Manufacturers

5 questions to ask a potential patient support partner when launching one of your first products

Manufacturers

5 questions to ask a potential patient support partner if you’re an established biopharma company

as patient and partner needs grow_center

Manufacturers

How biopharma can engage successfully with complex sites of care

Strategic partnerships for unlocking product potential ebook

Manufacturers

Support patient access in pharmacies by addressing affordability issues and coverage complexity

Manufacturers

Better together: Clinical specialists and field reimbursement and access specialists

Manufacturers

Report: Biosimilars usage is lowering costs for patients and the Medicare program

Manufacturers

Innovative logistics solutions for specialty medications

Manufacturers

Enhancing your patient assistance program’s efficiency with innovative digital solutions

Manufacturers

Best practices to advance patient support with emerging technology

PharmaLex, part of Cencora

Manufacturers

EU HTA 2025 readiness: Key methodological updates and practical tips on statistical guidelines

Michael Hennig, PhD

Manufacturers

Takeaways from Cencora’s inaugural Cell and Gene Therapy Summit

Adapting learnings to advance CGT clinical manufacturing

Christian Schneider, M.D.

Manufacturers

Leveraging past learnings for future-focused solutions to clinical manufacturing

PharmaLex

Manufacturers

Breaking barriers and moving forward: Reflections on impact and future directions for CGT

Lung-I Cheng

Biopharma Services

Manufacturers

A glimpse into the future of CGTs with ARM’s Rita Johnson-Greene

A light-skinned person with long brown hair holding a tablet and stylus smiles at a colleague during a meeting in a conference room.

From PICO anxiety to PICO strategy: planning for EU HTA success

Ruairi O'Donnell, PhD

Manufacturers

Accelerating product access: How channel strategy drives success for new product launches

Manufacturers

Get set for 2025: Mastering the new EU HTA statistical guidelines

Manufacturers

Value-Based Healthcare (VBHC): A game changer for pharma to accelerate patient access

Manufacturers

Patient support programs: A significant source of real-world data

Manufacturers

Real world evidence: The importance for rare disease therapies

Manufacturers

Case studies: Maximize your brand's visibility

Manufacturers

Innomar Strategies: Comprehensive 3PL and QA services

Manufacturers

QA and 3PL licences: Helping you stay compliant

Manufacturers

4 questions with Joanna Ng

Joanna Ng

Manufacturers

The power of patient engagement: A trailblazing journey to elevate access

Lung-I Cheng

Biopharma Services

Manufacturers

The power of patient engagement with CGT innovation

Manufacturers

Tackling the complex nature of the cell and gene therapy supply chain

Manufacturers

Navigating the supply chain maze: Overcoming challenges and optimizing logistics for CGTs

Andrea Zobel

World Courier

Manufacturers

Unlocking AMCP Format Version 5.0: Navigating updates and best practices for formulary dossiers

Manufacturers

Unsupported policy information: Insights from Jane Ha

Jane Ha, PharmD, MS

Manufacturers

Decoding payer perspectives: Insights from Ben Penley

Ben Penley

Manufacturers

Leveraging Pre-Approval Information Exchange to Accelerate Product Success and Patient Access

Alvana Maliqi

Christie Smith, PharmD, MBA

Manufacturers

7 questions with Dr. Christie Smith

Specialty Physician Services & Solutions

Manufacturers

Forging ahead with US and EU healthcare policy changes: balancing sustainability, innovation and patient access in the era of IRA and EU HTA

Manufacturers

A tsunami of regulations will require biopharma to look to the high ground of knowledgeable partners

Manufacturers

Discussing the ThinkLive Cell and Gene Therapy Summit

Manufacturers

Emerging biopharma Outlook Therapeutics shares the benefits of Cencora's international commercialization support

Manufacturers

Understanding how to energize, extend and capitalize the lifespan of mature drugs

Manufacturers

Value-Based Healthcare (VBHC): A game changer for pharma to accelerate patient access

Manufacturers

Unlocking success in cell and gene therapy distribution

Melissa Lattanzi

PharmaLex, part of Cencora

Manufacturers

Q&A on the latest guidelines for statistical analysis in EU Health Technology Assessment

Michael Hennig, PhD

Manufacturers

Webinar: Innovations in limited pharmacy networks to help pharmacies dispense your products

Manufacturers

Prepare your patient support program for IRA's impact

Manufacturers

4 questions with Ben Penley

Ben Penley

AB-Business-Meeting-Two-Males_RGB_Large-Square

Manufacturers

5 questions with Jane Ha

Jane Ha, PharmD, MS

Manufacturers

6 questions with Kyle Noonan

Kyle Noonan, PharmD, MS

Manufacturers

Recap AMCP 2024: Our thought leadership in action

Manufacturers

A Biosimilars Roadmap: Understanding Payer Perceptions

Animal Health

Who isn't getting veterinary care?

MWI Animal Health

Manufacturers

Webinar: Bracing for the Impact of Biosimilars: Navigating Terrain in the U.S. Market Landscape

FormularyDecisions

Manufacturers

Cell and Gene Therapy (CGT): Pre-launch checklist

Q&A Interview: Navigating the launch of ATMPs in Europe

Streamlined strategic support for long-term care pharmacy customers

Manufacturers

Exploring strategic partnerships: A conversation with Cencora leadership

Annika Brosig, PhD; Kristina Dittrich, PhD; Werner Kulp, PhD; Jan-Frederik Löpmeier-Röh, MSc; Edith Wehage, PhD

Manufacturers

Benefit-driven pricing: How AMNOG strikes a balance between the financial burden on statutory health insurance and reimbursement of innovative medications in Germany

Mareike Konstanski, MSc; Susanne Kossow, PhD; Ruairi O'Donnell, PhD; Kim Joline Schmidt, MSc

Manufacturers

Embarking on the EU HTAR realization journey: Key insights from the first of six implementing acts

David Ringger; Erika Wissinger, PhD

Manufacturers

EAMS evidence: A key player in drug value proposition and NICE approval?

Manufacturers

HTAQ Summer 2024